So called vaccine counters also red. So its not merely about gloves (and related) downtrending, but most of them. Ask bursa why intentionally supress all prices. I would rather donate my money to charity rather than bursa.
If your new vaccine come out, gloves demand still high under process vaccination. Don't scare people to throw their share to you, likely you want to collect at low price. Please play gentlemen, don't like a rat
Bursa malaysia interest on number of transaction rather than caring for regulating the share market . Most share up drastic without any news with no uma .
This counter is sound. At this level its OK to keep even long term This co gets the most direct to Glove Industry. They formulated their own products to sell to Glove Industry, not just trading. Profit margin is higher in this manner.
Another interesting data that can give a guide is the Insider trading by Co Directors and major shareholders. In June 2020, all were buying from 70+ to 80+ cents. During limit up day on 7th Aug 2020 they were disposing. The high price that day is $1.47 On 14 Aug they are all buying back again at 83 to 91.5 cents.
I ask a good friend in the Glove Industry about 3 listed Chemical Co that is listed. This is what he say Buy La Luxchem. Turnover 800+ million. They have factory making dispersion chemicals for Glove Industry. Samchem is not supplying much to Glove Ind. Only Potassium Hydroxide and some solvents. Texchem is not promising
Yes. Samchem is diversified and seems to be performing better. Luxchem cant even compete with their niche in the gloves sector. Why? There is another big unlisted supplier plus there is LC titan and Petronas chemicals. So margin is pretty thin until profits are challenged. So, it's better to be a small but effective player
Yes. Samchem is diversified and seems to be performing better. Luxchem cant even compete with their niche in the gloves sector. Why? There is another big unlisted supplier plus there is LC titan and Petronas chemicals. So margin is pretty thin until profits are challenged. So, it's better to be a small but effective player
Obviously you dun understand what Luxchem business doing. They are totally different with LC Titan and Petronas, or even Samchem. That's why you can't have a proper valuation view on them.
Lukesharewalker Yes. Samchem is diversified and seems to be performing better. Luxchem cant even compete with their niche in the gloves sector. Why? There is another big unlisted supplier plus there is LC titan and Petronas chemicals. So margin is pretty thin until profits are challenged. So, it's better to be a small but effective player 16/08/2020 4:24 PM
Samchem reported RM23.8 million profit last year - Market cap of 300 million Luxchem reported RM37.6 million profit last year - Market cap of 900 million
Huge upside for Samchem trading at a PE multiple of 12.5 currently compared to comparables of 20 + PE multiple
Say whatever you want on niche or glove, the results speaks for itself. Latest quarter, EPS of Samchem is 3.22 vs Luxchem of 0.85
wow. haha cant believe all blocks eaten! its good actually not to limit up but almost limit up, most importantly is Gap up huge when opening :) lets spread positivity and happy resting traders
DNONCE TECHNOLOGY Key Highlights • Significant improvement in Profit Before Tax (“PBT”) from loss of RM3.34 million in 1H Year-to-date (“YTD”) 30 June 2019 to RM2.40 million, an increase of RM5.74 million or 172% for Financial Year Ended 30 April 2020 (“FYE 30 April 2020”). • Noteworthy surge in revenue, average monthly sales for July 2019 till April 2020 was RM14.6 million compared with January 2019 till June 2019 of RM13.3 million representing a 9.8% increase, even though March and April sales were impacted by the Covid-19 induced MCO • Three consecutive profitable quarters with FYE PBT of RM2.40 million signifying 9 straight months of profit until April since the new management took over the running of the Company. D’nonce Technology Bhd (“D’nonce” or “the Group”) (“7114”), today announced its interim financial results for the sixth quarter (“Q6”) and 16-month consolidated financial results for its Financial Year Ended 30 April 2020 (“FYE 30 April 2020”). DNONCE is a diversified engineering solutions provider, serving customers in the semiconductor, automotive, medical/healthcare, data storage hardware and consumer electronics industries with overseas subsidiaries in Thailand. In mid-July 2019, D’nonce had installed a new Board of Directors and management, led by Mr. Tho Yow Yin as CEO. Under the new leadership. DNONCE embarked on costcutting measures and redirected their focus to expand the Group’s growth in value-added businesses. These efforts have borne positive results as reflected in its financial performance since July 2019 to 30 April 2020. D’nonce recorded a revenue of RM225 million for the FYE 30 April 2020, of which from 1 July 2019 to 30 April 2020, the Group recorded an average monthly revenue of RM14.6 million as compared to an average monthly revenue of RM13.3 million from 1 January 2019 to 30 June 2019, representing a 9.8% improvement in sales, despite the MCO which impacted operations in March and April 2020. The significant increment of the revenue was partly contributed by the surge in demand from customers in the healthcare industry mainly due to the Covid-19 outbreak as D’nonce provides essential support to the glove industry in Southern Thailand and also supplies injection molded ventilator parts from their factory in Prai, Pulau Pinang. Simultaneously, DNONCE continued to showcase a healthy and growing PBT having recorded a PBT of RM2.40 million for the Financial Period Ended 30 April 2020 reflecting a turnaround of RM5.74 million or 172% growth over the 1H Loss Before Tax of RM3.34 million. With the exception of Q6 FY2020 (which consisted of only 1 month), the Group achieved three consecutive quarters in the black (cumulative PBT of RM5.74 million from 1 July 2019 to 30 April 2020) - after losses earlier in the financial year throughout the first two quarters (cumulative Loss Before Tax of RM3.34 million from 1 January 2019 to 30 June 2019).
This is the result of the DNONCE Management’s continuous prudence in managing its expenses while expanding revenue, resulting in the highest level of operational efficiency and also the continuous growth of its business. As of 30th April 2020 the Group has generated a positive cash flow of RM8.16 million from operating activities and have cash and bank balances of RM32.5 million. For the full FYE 30 April 2020, D’nonce recorded a Profit After Tax of RM0.73 million (after the non-cash adjustment from the revaluation of properties deficit of RM0.45 million) in spite of the net losses recorded for Financial Period Ended 30 June 2019. Notwithstanding the challenging environment, DNONCE is cautiously optimistic of its business with the expectation of continued strong demand for its supplies to the medical and health sectors as well as the positive demand from the electronic technology sector moving forward. DNONCE has active initiatives underway to enhance its overall organisational effectiveness. These initiatives should increase productivity and cost efficiency while also helping to realise scale economies as Dnonce continues to grow its commercial opportunities.
两大利好围绕DNONCE!! 1)Provides Essential Support (Glove Industry) Southern Thailand
2) Injection Molded Ventilator Parts (Prai, Pulau Pinang)
yaa lao..boss always like that, buy lower and dispose at high price. how investors wanna trust/konfiden to invest in this stock? just my 2$. :) but for this time i really hope laa the boss dont do it again. let it fly higher. the managment shld be learn how to konfiden with their own bisness! not keep disposing the shre like before.
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
MQ Trader 304 views | 2 d ago
0:17
New IPO: The onshore and offshore support services provider for the O&G industry, Steel Hawk Bhd aims to list on the Ace Market!
MQ Trader 11526 views | 10 d ago
0:17
New IPO: The largest mini-market player and a leading groceries retailer in Malaysia, 99 Speed Mart Retail Holdings Bhd aims to list on the Main Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Silentreader88
920 posts
Posted by Silentreader88 > 2020-08-15 07:47 | Report Abuse
So called vaccine counters also red. So its not merely about gloves (and related) downtrending, but most of them. Ask bursa why intentionally supress all prices. I would rather donate my money to charity rather than bursa.